| 000 | 01210nam a22002777a 4500 | ||
|---|---|---|---|
| 001 | 06421 | ||
| 003 | HDC | ||
| 007 | cr bn ---aaaaa | ||
| 008 | 210123b20102010xxu||||| |||| 00| 0 eng d | ||
| 020 | _a9781439803363 | ||
| 040 | _aHDC | ||
| 100 |
_aAgalloco, James _eauthor _96842 |
||
| 245 | 0 |
_aValidation of active pharmaceutical ingredients _c/ James Agalloco and Phil DeSantis _b(Click "TITLE NOTES" below to request for the document) |
|
| 260 |
_aNew York: _bInforma Healthcare, _c2010 |
||
| 300 | _a1 online resource (19 pages) | ||
| 336 |
_atext _2rdacontent |
||
| 337 |
_acomputer _2rdamedia |
||
| 338 |
_aonline resource _2rdacarrier |
||
| 500 |
_aOriginally from: Active pharmaceutical ingredients : development, manufacturing, and regulation, 2010 (pages 144-162) _aIncludes bibliographical references _ahttps://hkc.hdcglobal.com/member/request-adhoc |
||
| 650 |
_aPharmaceutical industry _xQuality control _96534 |
||
| 700 |
_aDeSantis, Phil _ejoint author _96843 |
||
| 856 | _zRequest full-text at [email protected] | ||
| 942 | _2lcc | ||
| 942 | _cCHAP | ||
| 942 | _kEBCH 004263 | ||
| 999 |
_c3745 _d3745 |
||